Lazard Asset Management
HIMS icon

Lazard Asset Management’s Hims & Hers Health HIMS Stock Holding History

Lazard Asset Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Hold
12,048
– – ﹤0.01% 1477
2026
Q1 		$250K Sell
12,048
-373
-3% -$8.81K ﹤0.01% 1564
2025
Q4 		$403K Sell
12,421
-8,685
-41% -$372K ﹤0.01% 1443
2025
Q3 		$1.2M Sell
21,106
-3,033
-13% -$155K ﹤0.01% 1080
2025
Q2 		$1.2M Sell
24,139
-4,361
-15% -$197K ﹤0.01% 1224
2025
Q1 		$841K Buy
28,500
+6,926
+32% +$257K ﹤0.01% 1272
2024
Q4 		$520K Sell
21,574
-211,692
-91% -$5.24M ﹤0.01% 1354
2024
Q3 		$4.29M Buy
233,266
+71,678
+44% +$1.28M 0.01% 674
2024
Q2 		$3.26M Buy
+161,588
New +$2.69M ﹤0.01% 774
2023
Q1 		– Sell
-9,149
Closed -$58K – 2408
2022
Q4 		$58K Hold
9,149
– – ﹤0.01% 1733
2022
Q3 		$51K Buy
+9,149
New +$55.1K ﹤0.01% 1792

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lazard Asset Management's HIMS Position: Q2 2026 in Review

Lazard Asset Management held its Hims & Hers Health (HIMS) position steady in Q2 2026 at 12,048 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Lazard Asset Management first reported a position in HIMS in Q3 2022 and has held it in 11 quarters since. The position peaked at $4.29M in Q3 2024. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Lazard Asset Management held 12,048 shares of Hims & Hers Health worth $418K as of Q2 2026.
  • Lazard Asset Management left its Hims & Hers Health share count unchanged in Q2 2026.
  • Hims & Hers Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1477 holding.
  • Lazard Asset Management first reported a position in Hims & Hers Health in Q3 2022 and has held it in 11 quarters since.
  • Lazard Asset Management's Hims & Hers Health position peaked at $4.29M in Q3 2024.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.